ROSEN, LEAD INVESTOR ADVISOR, encourages Acadia Healthcare Company, Inc. investors with losses greater than $100,000 to secure an advisor before the important Dec. 16 deadline at Investing.com



New York, NY–(Newsfile Corp. – December 15, 2024) – WHY: The Rosen Law Firm, a global investor rights law firm, reminds securities buyers to Acadia Healthcare (NASDAQ:) Company, Inc. (NASDAQ: ACHC ) between February 28, 2020 and October 18, 2024, both dates (the “Teaching Period”), significant December 16, 2024 deadline for the chief prosecutor in a securities suit first filed by the Firm.

SO WHAT: If you purchased Acadia Healthcare securities during the class period, you may be entitled to reimbursement without paying any fees or out-of-pocket expenses through a contingency fee arrangement.

WHAT’S NEXT: To join the Acadia Healthcare class action, go to https://rosenlegal.com/submit-form/?case_id=28482 or call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for class action information. A class action lawsuit has already been filed. If you want to be the chief prosecutor, you have to move the court no later than 16.12.2024. The lead plaintiff is the representative party acting on behalf of other class members in the conduct of the litigation.

WHY ROSEN LAW: We encourage investors to select a qualified advisor with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any significant peer recognition. Many of these firms do not actually litigate securities class actions, but are merely brokers who refer clients or partners with law firms that actually litigate. Be wise in choosing an advisor. The Rosen Law Firm represents investors worldwide, concentrating its practice on securities class actions and shareholder derivative litigation. The Rosen Law Firm achieved the largest securities settlement against a Chinese company at that time. The Rosen Law Firm is ranked #1 by ISS Securities Class Action (VA:) Services for the number of securities settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the firm secured over $438 million for investors. In 2020, founding partner Lawrence Rosen was named a Titan of the Plaintiffs Bar Association by Law360. Lovedragon and Super Laviers have recognized many of the firm’s lawyers.

CASE DETAILS: According to the complaint, the defendants throughout the period made materially false and/or misleading statements and/or failed to disclose that: (1) Acadia Healthcare’s business model focused on holding vulnerable people against their will in its facilities, including when it was not was medically necessary for it; (2) while at Acadia Healthcare facilities, many patients were subjected to abuse; (3) Acadia Healthcare defrauded insurance providers into paying patients to stay in its facilities when it was not medically necessary; and (4) as a result, Defendants’ statements about its business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details came to market, the lawsuit claims investors suffered damages.

To join the Acadia Healthcare class action, go to https://rosenlegal.com/submit-form/?case_id=28482 call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for class action information.

No class is certified. Until the class is certified, you are not represented by an attorney unless you retain one. You can choose a lawyer of your choice. You can also remain an absent member of the class and do nothing at this time. An investor’s ability to participate in a potential future recovery does not depend on whether it is the lead plaintiff.

Follow us for updates on LinkedIn: https://vvv.linkedin.com/company/the-rosen-lav-firm or on Twitter: https://tvitter.com/rosen_firm or on Facebook (NASDAK:) : https:/ /vvv.facebook.com/rosenlavfirm.

Advertising Advertising. Previous results do not guarantee a similar outcome.

——————————

To view the original version of this press release, visit https://www.nevsfilecorp.com/release/233825



Leave a Reply

Your email address will not be published. Required fields are marked *